Jupiter Life Line Hospitals Ltd (JLHL) — shareholding pattern, promoter holding, financials and share price
About Jupiter Life Line Hospitals Ltd (JLHL)
Jupiter Life Line Hospitals Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as JLHL and on the BSE under scrip code 543980. Its ISIN is INE682M01012.
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India. [1]
Jupiter Life Line Hospitals Limited is a multi-speciality healthcare provider based in Western India, with facilities in Thane, Pune, and Indore, and a new hospital in Dombivli. Their core business involves tertiary and quaternary medical services across over 30 specialties.
The company successfully completed a significant capex project, a 500-bed hospital in Dombivli, ahead of schedule, exemplifying efficient project execution strategies under budget constraints.
Listed peers in Hospital: Rainbow Childrens Medicare Ltd, Park Medi World Ltd, Healthcare Global Enterprises Ltd, Yatharth Hospital & Trauma Care Services Ltd, Kovai Medical Center & Hospital Ltd, Artemis Medicare Services Ltd.
Valuation & Returns
10 Jul 2026At ₹1,440.8 a share on 10 Jul 2026, Jupiter Life Line Hospitals Ltd (JLHL) was valued at a price-to-earnings ratio of 48.66x against an industry P/E of 61.73x and a price-to-book of 6.12x on a book value of ₹235.5 per share as of Mar 2026. Solomo computes return on equity of 12.57% and return on capital employed of 13.76% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 48.66x
- Industry P/E
- 61.73x
- P/B
- 6.12x
- EPS (TTM)
- ₹29.61
- Book value / share
- ₹235.5
- ROE
- 12.57%
- ROCE
- 13.76%
- ROA
- 8.15%
- Debt / equity
- 0.38x
- Dividend yield
- 0.07%
- EBITDA margin
- 25.39%
- 52-week range
- ₹1,152.05 – ₹1,618.15
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Jupiter Life Line Hospitals Ltd (JLHL) reported revenue of ₹1,500 crore, net profit of ₹194 crore and earnings per share of ₹29.59. That compares with revenue of ₹1,302 crore and net profit of ₹194 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹388 crore and net profit ₹50 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 733 | 893 | 1,073 | 1,302 | 1,500 |
| Net profit (₹ cr) | 51 | 73 | 177 | 194 | 194 |
| EPS (₹) | 10.05 | 12.9 | 26.94 | 29.47 | 29.59 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 21.03% | 15.01% | 15.16% |
| Profit growth | 63.08% | 21.31% | 0.23% |
| Stock price CAGR | - | - | 4% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 40.91% of Jupiter Life Line Hospitals Ltd (JLHL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 9.37% and domestic institutional investors (DII) hold 16.51%. Market capitalisation was ₹9,447 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Jun 2026: SBI HEALTHCARE OPPORTUNITIES FUND 7.77%, JM FINANCIAL PRODUCTS LIMITED 3.42%, GOLDMAN SACHS FUNDS -GOLDMAN SACHSINDIA EQUITY P 2.75%, MIHIR WIRE INDUSTRIES PVT LTD 2.15%, SBI LIFE INSURANCE CO. LTD 2.01%, DR NAVIN RAMJI DAVDA 2%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 40.91% | - | 9.37% | 16.51% | 59.09% |
| Mar 2026 | 40.91% | - | 8.48% | 17.01% | 59.09% |
| Dec 2025 | 40.91% | - | 8.48% | 17.43% | 59.09% |
| Sep 2025 | 40.91% | - | 9.06% | 16.95% | 59.09% |
| Jun 2025 | 40.91% | - | 9.77% | 15.82% | 59.09% |
| Mar 2025 | 40.91% | - | 10.03% | 15.63% | 59.09% |
| Dec 2024 | 40.91% | - | 10.04% | 15.74% | 59.09% |
| Sep 2024 | 40.91% | - | 8.84% | 16.87% | 59.09% |